Zydus begins human trials for potential COVID-19 vaccine
In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India
![Indian pharmaceutical company Zydus started human studies for its potential COVID-19 vaccine. (AP Photo) Indian pharmaceutical company Zydus started human studies for its potential COVID-19 vaccine. (AP Photo)](https://s3.ap-southeast-1.amazonaws.com/images.asianage.com/images/aa-Cover-qo4lkc94037m2ug36rq5r9q8a6-20200715103336.Medi.jpeg)
Indian pharmaceutical company Zydus started human studies for its potential COVID-19 vaccine. (AP Photo)
BENGALURU: Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential COVID-19 vaccine, as coronavirus infections continue to surge in the world’s third worst-hit nation.
ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies, Zydus said.
In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India.
Next Story